AKBULUT, H. Et Al. 2016. The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC). ANNALS OF ONCOLOGY , vol.27 .

AKBULUT, H., Ocal, M., Sonugur, G., AKAY, B. N., BABAHAN, C., Abgarmi, S. A., ... DEMİRKAZIK, A.(2016). The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC). ANNALS OF ONCOLOGY , vol.27.

AKBULUT, HAKAN Et Al. "The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)," ANNALS OF ONCOLOGY , vol.27, 2016

AKBULUT, HAKAN Et Al. "The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)." ANNALS OF ONCOLOGY , vol.27, 2016

AKBULUT, H. Et Al. (2016) . "The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)." ANNALS OF ONCOLOGY , vol.27.

@article{article, author={HAKAN AKBULUT Et Al. }, title={The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)}, journal={ANNALS OF ONCOLOGY}, year=2016}